Schisandrin B exhibits anti‑proliferative effects by inducing ferroptosis in pancreatic cancer
Oncology Reports · 16.06.2026 · 56 (2) · 1-16
DOI: 10.3892/or.2026.9152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, online erschienen am 16.06.2026. Verfasst von Fengjin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Digestive Diseases, The Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, Guangdong 511…. Hauptthemen laut MEDLINE: Ferroptosis, Polycyclic Compounds, Pancreatic Neoplasms, Lignans. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Digestive Diseases, The Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, Guangdong 511518, P.R. China.
- Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan 610047, P.R. China.
Zitieren
APA
Li, F., Fu, J., Lin, X., Liu, Y., Yang, L., Li, Y., Peng, T., & Qi, L. (2026). Schisandrin B exhibits anti‑proliferative effects by inducing ferroptosis in pancreatic cancer. Oncology Reports, 56(2), 1-16. https://doi.org/10.3892/or.2026.9152
Vancouver
Li F, Fu J, Lin X, Liu Y, Yang L, Li Y, et al. Schisandrin B exhibits anti‑proliferative effects by inducing ferroptosis in pancreatic cancer. Oncology Reports. 2026;56(2):1-16. doi:10.3892/or.2026.9152
BibTeX
@article{Li2026,
author = {Li, Fengjin and Fu, Jiacai and Lin, Xiaowei and Liu, Yanting and Yang, Lu and Li, Yuxin and Peng, Tieli and Qi, Ling},
title = {Schisandrin B exhibits anti‑proliferative effects by inducing ferroptosis in pancreatic cancer},
journal = {Oncology Reports},
year = {2026},
volume = {56},
number = {2},
pages = {1--16},
doi = {10.3892/or.2026.9152}
}
EUVIMED